Skip to main content
. 2020 Jul 21;40:18. doi: 10.1186/s41232-020-00118-7

Fig. 5.

Fig. 5

Role of TLR9 in the development of cardiometabolic disorders. DNA fragments and/or nuclear proteins released from damaged cells/tissues activate immune cells such as macrophages and DCs through TLR9, leading to the development of inflammation in these tissues, which is central in the pathogenesis of cardiometabolic disorders